piritrexim has been researched along with Carcinoma, Transitional Cell in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreicer, R; Graham, D; Manola, J; Roth, BJ; Wilding, G | 1 |
| Carducci, MA; Hussain, MH; Lassiter, LK; Petrylak, DP; Stadler, WM; Tummala, MK | 1 |
| Benedetto, P; Clendennin, NJ; Collier, M; Feun, LG; Savaraj, N; Waldman, S | 1 |
| de Wit, R; Kaye, SB; Roberts, JT; Scott, J; Stoter, G; Verweij, J | 1 |
| de Wit, R; Slingerland, R; Stoter, G; Verweij, J | 1 |
| Clendeninn, NJ; Collier, M; Feun, L; Khorsand, M; Lange, J; Wilding, G | 1 |
| Donnelly, E; Feun, LG; Ganjei, P; Hussein, AM; Savaraj, N | 1 |
5 trial(s) available for piritrexim and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Piritrexim in advanced, refractory carcinoma of the urothelium (E3896): a phase II trial of the Eastern Cooperative Oncology Group.
Topics: Aged; Aged, 80 and over; Antineoplastic Protocols; Carcinoma, Transitional Cell; Female; Humans; Male; Middle Aged; Pyrimidines; United States; Urologic Neoplasms; Urothelium | 2002 |
Phase II open-label study of oral piritrexim in patients with advanced carcinoma of the urothelium who have experienced failure with standard chemotherapy.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Folic Acid Antagonists; Humans; Middle Aged; Pyrimidines; Treatment Outcome; Urologic Neoplasms | 2008 |
Oral piritrexim, an effective treatment for metastatic urothelial cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Male; Methotrexate; Middle Aged; Pyrimidines; Urologic Neoplasms | 1993 |
Piritrexim-induced pulmonary toxicity.
Topics: Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Pulmonary Fibrosis; Pyrimidines | 1993 |
Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pyrimidines; Urinary Bladder Neoplasms | 1997 |
2 other study(ies) available for piritrexim and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Oral piritrexim in advanced bladder cancer: an effective drug after progression on MVAC chemotherapy?
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Pyrimidines; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Carcinomatous meningitis from transitional cell carcinoma of the bladder: case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Humans; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Pyrimidines; Urinary Bladder Neoplasms | 1989 |